LC2 - Conditionnement

Packaging / References: C.S.P. / B.P.F.

LC² designs the packaging of pharmaceutical units rigorously and to order with a view to:

make it easier for patients to keep to their treatments,
facilitate identification of treatment periods by medical practitioners on site,
optimise distribution operations (including protecting products, ensuring transport safety, improving the weight/volume ration of parcels, including manuals and documents).
respecting the brand name images of principals.

Adaptability :
• Smallest series packaged: 8 25x 100 mm blister packs.
• Largest series packaged: 13 pallets/week for twelve weeks
Activities other than clinical trials:
• reprocessing of industrial batches.

Photos © Norbert Jung / esprit-photo.com

Primary packaging: DRY FORMS

Batch type	Masking	Blister pack	Pill box	Working conditions
Clinical batches	Yes	Yes	Yes	Class D level Relative humidity: < 30% Temperature: + 20°C 100% Semi- automatic process
Stability test batches	-	Yes	Yes
Pilot batches	-	Yes	-
Bioequivalence test	-	-	Yes

LC² has built up a close relationship with nearby pharmaceutical establishments to produce placebo units and for packaging that must be carried out under insulation. As sub-contractors of LC² for pharmaceutical operations, these companies undergo regular and thorough reassessments by our Quality Assurance department.

Outer packaging: ALL FORMS

Batch type	Operation
Clinical batches Bioequivalence test batches	Labelling Blister pack cards Boxed
Marketed batches: . pharmaceutical products . cosmetic products . nutrition products . biomedical equipment	Labelling De- / re-labelling Sorting Changing instruction leaflet Deviated ink-jet printing
Documentation Investigateurs	Multi-pack

The above list of outer packaging operations is not intended to be exhaustive.
LC² has always carried out changes in its operating authorisations linked to the implementation of a new service rapidly. In this way the company researched and obtained authorisation for the use of level one new biotechnology products following a customer’s order.

Thanks to its industrial vocation, LC² has developed its ability to reprocess batches of marketed health products, industrial scale batches, or multiple series of remainders of industrial batches. We treat such orders with the care and attention (precision, adaptability and responsiveness) as we bring to products for clinical trials. This means that we can react efficiently to problems linked to changes in price (or repayment rates), interruptions in supplies (involving a change in service provider) and production problems (such as sorting capsules, searching for damaged units, etc.).

LC² is equipped with a flexible, high-performance packaging tool, has selected its suppliers for their ability to work the best materials faultlessly to strict deadlines. Equipment and materials are implemented by our qualified staff under the supervision of pharmacists and in the framework of our quality system. Our working documents enable all work carried out to be recorded in order to ensure the traceability of operations on products and to guarantee complete transparency between the principal and LC².